Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib.
Condoluci A, Milan L, Forestieri G, Terzi di Bergamo L, Spina V, Bruscaggin A, Deambrogi C, Moia R, Deodato M, Fahrni G, Mattarucchi R, Merli M, Gerber B, Stussi G, Passamonti F, Gregor M, Tedeschi A, Gaidano G, Rossi D, Ceriani L.
Condoluci A, et al. Among authors: rossi d.
Hematol Oncol. 2022 Dec;40(5):1105-1108. doi: 10.1002/hon.3039. Epub 2022 Jun 8.
Hematol Oncol. 2022.
PMID: 35656838
No abstract available.